Cargando…
Nanosized UCMSC-derived extracellular vesicles but not conditioned medium exclusively inhibit the inflammatory response of stimulated T cells: implications for nanomedicine
Undesired immune responses have drastically hampered outcomes after allogeneic organ transplantation and cell therapy, and also lead to inflammatory diseases and autoimmunity. Umbilical cord mesenchymal stem cells (UCMSCs) have powerful regenerative and immunomodulatory potential, and their secreted...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5197063/ https://www.ncbi.nlm.nih.gov/pubmed/28042333 http://dx.doi.org/10.7150/thno.16154 |
_version_ | 1782488616774139904 |
---|---|
author | Monguió-Tortajada, Marta Roura, Santiago Gálvez-Montón, Carolina Pujal, Josep Maria Aran, Gemma Sanjurjo, Lucía Franquesa, Marcel·la Sarrias, Maria-Rosa Bayes-Genis, Antoni Borràs, Francesc E. |
author_facet | Monguió-Tortajada, Marta Roura, Santiago Gálvez-Montón, Carolina Pujal, Josep Maria Aran, Gemma Sanjurjo, Lucía Franquesa, Marcel·la Sarrias, Maria-Rosa Bayes-Genis, Antoni Borràs, Francesc E. |
author_sort | Monguió-Tortajada, Marta |
collection | PubMed |
description | Undesired immune responses have drastically hampered outcomes after allogeneic organ transplantation and cell therapy, and also lead to inflammatory diseases and autoimmunity. Umbilical cord mesenchymal stem cells (UCMSCs) have powerful regenerative and immunomodulatory potential, and their secreted extracellular vesicles (EVs) are envisaged as a promising natural source of nanoparticles to increase outcomes in organ transplantation and control inflammatory diseases. However, poor EV preparations containing highly-abundant soluble proteins may mask genuine vesicular-associated functions and provide misleading data. Here, we used Size-Exclusion Chromatography (SEC) to successfully isolate EVs from UCMSCs-conditioned medium. These vesicles were defined as positive for CD9, CD63, CD73 and CD90, and their size and morphology characterized by NTA and cryo-EM. Their immunomodulatory potential was determined in polyclonal T cell proliferation assays, analysis of cytokine profiles and in the skewing of monocyte polarization. In sharp contrast to the non-EV containing fractions, to the complete conditioned medium and to ultracentrifuged pellet, SEC-purified EVs from UCMSCs inhibited T cell proliferation, resembling the effect of parental UCMSCs. Moreover, while SEC-EVs did not induce cytokine response, the non-EV fractions, conditioned medium and ultracentrifuged pellet promoted the secretion of pro-inflammatory cytokines by polyclonally stimulated T cells and supported Th17 polarization. In contrast, EVs did not induce monocyte polarization, but the non-EV fraction induced CD163 and CD206 expression and TNF-α production in monocytes. These findings increase the growing evidence confirming that EVs are an active component of MSC's paracrine immunosuppressive function and affirm their potential for therapeutics in nanomedicine. In addition, our results highlight the importance of well-purified and defined preparations of MSC-derived EVs to achieve the immunosuppressive effect. |
format | Online Article Text |
id | pubmed-5197063 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-51970632017-01-01 Nanosized UCMSC-derived extracellular vesicles but not conditioned medium exclusively inhibit the inflammatory response of stimulated T cells: implications for nanomedicine Monguió-Tortajada, Marta Roura, Santiago Gálvez-Montón, Carolina Pujal, Josep Maria Aran, Gemma Sanjurjo, Lucía Franquesa, Marcel·la Sarrias, Maria-Rosa Bayes-Genis, Antoni Borràs, Francesc E. Theranostics Research Paper Undesired immune responses have drastically hampered outcomes after allogeneic organ transplantation and cell therapy, and also lead to inflammatory diseases and autoimmunity. Umbilical cord mesenchymal stem cells (UCMSCs) have powerful regenerative and immunomodulatory potential, and their secreted extracellular vesicles (EVs) are envisaged as a promising natural source of nanoparticles to increase outcomes in organ transplantation and control inflammatory diseases. However, poor EV preparations containing highly-abundant soluble proteins may mask genuine vesicular-associated functions and provide misleading data. Here, we used Size-Exclusion Chromatography (SEC) to successfully isolate EVs from UCMSCs-conditioned medium. These vesicles were defined as positive for CD9, CD63, CD73 and CD90, and their size and morphology characterized by NTA and cryo-EM. Their immunomodulatory potential was determined in polyclonal T cell proliferation assays, analysis of cytokine profiles and in the skewing of monocyte polarization. In sharp contrast to the non-EV containing fractions, to the complete conditioned medium and to ultracentrifuged pellet, SEC-purified EVs from UCMSCs inhibited T cell proliferation, resembling the effect of parental UCMSCs. Moreover, while SEC-EVs did not induce cytokine response, the non-EV fractions, conditioned medium and ultracentrifuged pellet promoted the secretion of pro-inflammatory cytokines by polyclonally stimulated T cells and supported Th17 polarization. In contrast, EVs did not induce monocyte polarization, but the non-EV fraction induced CD163 and CD206 expression and TNF-α production in monocytes. These findings increase the growing evidence confirming that EVs are an active component of MSC's paracrine immunosuppressive function and affirm their potential for therapeutics in nanomedicine. In addition, our results highlight the importance of well-purified and defined preparations of MSC-derived EVs to achieve the immunosuppressive effect. Ivyspring International Publisher 2017-01-01 /pmc/articles/PMC5197063/ /pubmed/28042333 http://dx.doi.org/10.7150/thno.16154 Text en © Ivyspring International Publisher. Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. See http://ivyspring.com/terms for terms and conditions. |
spellingShingle | Research Paper Monguió-Tortajada, Marta Roura, Santiago Gálvez-Montón, Carolina Pujal, Josep Maria Aran, Gemma Sanjurjo, Lucía Franquesa, Marcel·la Sarrias, Maria-Rosa Bayes-Genis, Antoni Borràs, Francesc E. Nanosized UCMSC-derived extracellular vesicles but not conditioned medium exclusively inhibit the inflammatory response of stimulated T cells: implications for nanomedicine |
title | Nanosized UCMSC-derived extracellular vesicles but not conditioned medium exclusively inhibit the inflammatory response of stimulated T cells: implications for nanomedicine |
title_full | Nanosized UCMSC-derived extracellular vesicles but not conditioned medium exclusively inhibit the inflammatory response of stimulated T cells: implications for nanomedicine |
title_fullStr | Nanosized UCMSC-derived extracellular vesicles but not conditioned medium exclusively inhibit the inflammatory response of stimulated T cells: implications for nanomedicine |
title_full_unstemmed | Nanosized UCMSC-derived extracellular vesicles but not conditioned medium exclusively inhibit the inflammatory response of stimulated T cells: implications for nanomedicine |
title_short | Nanosized UCMSC-derived extracellular vesicles but not conditioned medium exclusively inhibit the inflammatory response of stimulated T cells: implications for nanomedicine |
title_sort | nanosized ucmsc-derived extracellular vesicles but not conditioned medium exclusively inhibit the inflammatory response of stimulated t cells: implications for nanomedicine |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5197063/ https://www.ncbi.nlm.nih.gov/pubmed/28042333 http://dx.doi.org/10.7150/thno.16154 |
work_keys_str_mv | AT monguiotortajadamarta nanosizeducmscderivedextracellularvesiclesbutnotconditionedmediumexclusivelyinhibittheinflammatoryresponseofstimulatedtcellsimplicationsfornanomedicine AT rourasantiago nanosizeducmscderivedextracellularvesiclesbutnotconditionedmediumexclusivelyinhibittheinflammatoryresponseofstimulatedtcellsimplicationsfornanomedicine AT galvezmontoncarolina nanosizeducmscderivedextracellularvesiclesbutnotconditionedmediumexclusivelyinhibittheinflammatoryresponseofstimulatedtcellsimplicationsfornanomedicine AT pujaljosepmaria nanosizeducmscderivedextracellularvesiclesbutnotconditionedmediumexclusivelyinhibittheinflammatoryresponseofstimulatedtcellsimplicationsfornanomedicine AT arangemma nanosizeducmscderivedextracellularvesiclesbutnotconditionedmediumexclusivelyinhibittheinflammatoryresponseofstimulatedtcellsimplicationsfornanomedicine AT sanjurjolucia nanosizeducmscderivedextracellularvesiclesbutnotconditionedmediumexclusivelyinhibittheinflammatoryresponseofstimulatedtcellsimplicationsfornanomedicine AT franquesamarcella nanosizeducmscderivedextracellularvesiclesbutnotconditionedmediumexclusivelyinhibittheinflammatoryresponseofstimulatedtcellsimplicationsfornanomedicine AT sarriasmariarosa nanosizeducmscderivedextracellularvesiclesbutnotconditionedmediumexclusivelyinhibittheinflammatoryresponseofstimulatedtcellsimplicationsfornanomedicine AT bayesgenisantoni nanosizeducmscderivedextracellularvesiclesbutnotconditionedmediumexclusivelyinhibittheinflammatoryresponseofstimulatedtcellsimplicationsfornanomedicine AT borrasfrancesce nanosizeducmscderivedextracellularvesiclesbutnotconditionedmediumexclusivelyinhibittheinflammatoryresponseofstimulatedtcellsimplicationsfornanomedicine |